Global Patient-derived Xenograft (PDX) Models Competitive Landscape Professional Research Report 2025
Market Overview
According to DIResearch's in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach 451.56 Million USD in 2025 and is projected to reach 777.92 Million USD by 2032, with a CAGR of 8.08% (2025-2032). Notably, the China Patient-derived Xenograft (PDX) Models market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient's tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient's cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor's real-world behavior.
The major global suppliers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Patient-derived Xenograft (PDX) Models Include:
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
Patient-derived Xenograft (PDX) Models Product Segment Include:
Mouse Model
Rat Model
Patient-derived Xenograft (PDX) Models Product Application Include:
Preclinical Drug development
Biomarker Analysis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis
Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter’s Five Forces Analysis
Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size and Forecast Analysis
Chapter 5: Global Patient-derived Xenograft (PDX) Models Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach 451.56 Million USD in 2025 and is projected to reach 777.92 Million USD by 2032, with a CAGR of 8.08% (2025-2032). Notably, the China Patient-derived Xenograft (PDX) Models market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient's tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient's cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor's real-world behavior.
The major global suppliers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Patient-derived Xenograft (PDX) Models Include:
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
Patient-derived Xenograft (PDX) Models Product Segment Include:
Mouse Model
Rat Model
Patient-derived Xenograft (PDX) Models Product Application Include:
Preclinical Drug development
Biomarker Analysis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis
Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter’s Five Forces Analysis
Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size and Forecast Analysis
Chapter 5: Global Patient-derived Xenograft (PDX) Models Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
1 PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET OVERVIEW
1.1 Product Definition and Statistica Sclope
1.2 Patient-derived Xenograft (PDX) Models Product by Type
1.2.1 Mouse Model
1.2.2 Rat Model
1.3 Patient-derived Xenograft (PDX) Models Product by Application
1.3.1 Preclinical Drug development
1.3.2 Biomarker Analysis
1.4 Global Patient-derived Xenograft (PDX) Models Market Size Analysis (2020-2032)
1.5 Patient-derived Xenograft (PDX) Models Market Development Status and Trends
1.5.1 Patient-derived Xenograft (PDX) Models Industry Development Status Analysis
1.5.2 Patient-derived Xenograft (PDX) Models Industry Development Trends Analysis
2 PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET ANALYSIS BY REGIONS
4.1 Global Patient-derived Xenograft (PDX) Models Overall Market: 2024 VS 2025 VS 2032
4.2 Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share by Region (2020-2025)
4.2.2 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2032)
5.2 Global Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Type
6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Application
6.5 North America Patient-derived Xenograft (PDX) Models Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Type
7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Application
7.5 Europe Patient-derived Xenograft (PDX) Models Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Patient-derived Xenograft (PDX) Models Market Size by Type
8.4 China Patient-derived Xenograft (PDX) Models Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Type
9.4 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Application
9.5 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Type
10.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Application
10.5 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type
11.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application
11.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Suppliers (2021-2025)
12.2 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis and Market Dynamic
12.2.1 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Crown Bioscience
13.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio
13.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Champions Oncology
13.2.1 Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio
13.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Wuxi Apptec
13.3.1 Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio
13.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 The Jackson Laboratory
13.4.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio
13.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 EPO Berlin-Buch
13.5.1 EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio
13.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Oncodesign
13.6.1 Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio
13.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Xentech
13.7.1 Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Portfolio
13.7.3 Xentech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Envigo
13.8.1 Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Portfolio
13.8.3 Envigo Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Charles River Laboratories
13.9.1 Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio
13.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Pharmatest Services
13.10.1 Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio
13.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Urosphere
13.11.1 Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio
13.11.3 Urosphere Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 MEDICILON
13.12.1 MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio
13.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 Horizon Discovery
13.13.1 Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio
13.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Shanghai Model Organisms Center
13.14.1 Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio
13.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 GemPharmatech
13.15.1 GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio
13.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.16 LIDE Biotech
13.16.1 LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio
13.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Patient-derived Xenograft (PDX) Models Industry Chain Analysis
14.2 Patient-derived Xenograft (PDX) Models Typical Downstream Customers
14.3 Patient-derived Xenograft (PDX) Models Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
1.1 Product Definition and Statistica Sclope
1.2 Patient-derived Xenograft (PDX) Models Product by Type
1.2.1 Mouse Model
1.2.2 Rat Model
1.3 Patient-derived Xenograft (PDX) Models Product by Application
1.3.1 Preclinical Drug development
1.3.2 Biomarker Analysis
1.4 Global Patient-derived Xenograft (PDX) Models Market Size Analysis (2020-2032)
1.5 Patient-derived Xenograft (PDX) Models Market Development Status and Trends
1.5.1 Patient-derived Xenograft (PDX) Models Industry Development Status Analysis
1.5.2 Patient-derived Xenograft (PDX) Models Industry Development Trends Analysis
2 PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET ANALYSIS BY REGIONS
4.1 Global Patient-derived Xenograft (PDX) Models Overall Market: 2024 VS 2025 VS 2032
4.2 Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share by Region (2020-2025)
4.2.2 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL PATIENT-DERIVED XENOGRAFT (PDX) MODELS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2032)
5.2 Global Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Type
6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Application
6.5 North America Patient-derived Xenograft (PDX) Models Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Type
7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Application
7.5 Europe Patient-derived Xenograft (PDX) Models Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Patient-derived Xenograft (PDX) Models Market Size by Type
8.4 China Patient-derived Xenograft (PDX) Models Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Type
9.4 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Application
9.5 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Type
10.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Application
10.5 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type
11.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application
11.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Suppliers (2021-2025)
12.2 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis and Market Dynamic
12.2.1 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Crown Bioscience
13.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio
13.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Champions Oncology
13.2.1 Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio
13.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Wuxi Apptec
13.3.1 Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio
13.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 The Jackson Laboratory
13.4.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio
13.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 EPO Berlin-Buch
13.5.1 EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio
13.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Oncodesign
13.6.1 Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio
13.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Xentech
13.7.1 Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Portfolio
13.7.3 Xentech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Envigo
13.8.1 Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Portfolio
13.8.3 Envigo Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Charles River Laboratories
13.9.1 Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio
13.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Pharmatest Services
13.10.1 Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio
13.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Urosphere
13.11.1 Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio
13.11.3 Urosphere Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 MEDICILON
13.12.1 MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio
13.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 Horizon Discovery
13.13.1 Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio
13.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Shanghai Model Organisms Center
13.14.1 Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio
13.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 GemPharmatech
13.15.1 GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio
13.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.16 LIDE Biotech
13.16.1 LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio
13.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Patient-derived Xenograft (PDX) Models Industry Chain Analysis
14.2 Patient-derived Xenograft (PDX) Models Typical Downstream Customers
14.3 Patient-derived Xenograft (PDX) Models Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
LIST OF TABLES
Table 1: Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Patient-derived Xenograft (PDX) Models Industry Development Status
Table 4: Patient-derived Xenograft (PDX) Models Industry Development Trends
Table 5: Global Patient-derived Xenograft (PDX) Models Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Patient-derived Xenograft (PDX) Models Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Region (2020-2025)
Table 8: Global Patient-derived Xenograft (PDX) Models Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Patient-derived Xenograft (PDX) Models Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Patient-derived Xenograft (PDX) Models Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Patient-derived Xenograft (PDX) Models Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Patient-derived Xenograft (PDX) Models Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Patient-derived Xenograft (PDX) Models Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Patient-derived Xenograft (PDX) Models Players in North America
Table 15: North America Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Patient-derived Xenograft (PDX) Models Players in Europe
Table 22: Europe Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Patient-derived Xenograft (PDX) Models Players in China
Table 29: China Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Patient-derived Xenograft (PDX) Models Players in APAC (excl. China)
Table 34: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Patient-derived Xenograft (PDX) Models Players in Latin America
Table 41: Latin America Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Patient-derived Xenograft (PDX) Models Players in Middle East & Africa
Table 48: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio
Table 60: Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio
Table 63: Champions Oncology Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio
Table 66: Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio
Table 69: The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio
Table 72: EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio
Table 75: Oncodesign Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Xentech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 78: Xentech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: Envigo Patient-derived Xenograft (PDX) Models Product Portfolio
Table 81: Envigo Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio
Table 84: Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio
Table 87: Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio
Table 90: Urosphere Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 92: MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio
Table 93: MEDICILON Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 94: Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 95: Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio
Table 96: Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 97: Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 98: Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio
Table 99: Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 100: GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 101: GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 102: GemPharmatech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 103: LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 104: LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 105: LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 106: Patient-derived Xenograft (PDX) Models Typical Customer List
Table 107: Patient-derived Xenograft (PDX) Models Distributors List
Table 1: Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Patient-derived Xenograft (PDX) Models Industry Development Status
Table 4: Patient-derived Xenograft (PDX) Models Industry Development Trends
Table 5: Global Patient-derived Xenograft (PDX) Models Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Patient-derived Xenograft (PDX) Models Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Region (2020-2025)
Table 8: Global Patient-derived Xenograft (PDX) Models Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Patient-derived Xenograft (PDX) Models Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Patient-derived Xenograft (PDX) Models Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Patient-derived Xenograft (PDX) Models Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Patient-derived Xenograft (PDX) Models Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Patient-derived Xenograft (PDX) Models Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Patient-derived Xenograft (PDX) Models Players in North America
Table 15: North America Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Patient-derived Xenograft (PDX) Models Players in Europe
Table 22: Europe Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Patient-derived Xenograft (PDX) Models Players in China
Table 29: China Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Patient-derived Xenograft (PDX) Models Players in APAC (excl. China)
Table 34: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Patient-derived Xenograft (PDX) Models Players in Latin America
Table 41: Latin America Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Patient-derived Xenograft (PDX) Models Players in Middle East & Africa
Table 48: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio
Table 60: Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio
Table 63: Champions Oncology Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio
Table 66: Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio
Table 69: The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio
Table 72: EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio
Table 75: Oncodesign Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Xentech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 78: Xentech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: Envigo Patient-derived Xenograft (PDX) Models Product Portfolio
Table 81: Envigo Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio
Table 84: Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio
Table 87: Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio
Table 90: Urosphere Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 92: MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio
Table 93: MEDICILON Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 94: Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 95: Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio
Table 96: Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 97: Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 98: Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio
Table 99: Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 100: GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 101: GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 102: GemPharmatech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 103: LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 104: LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio
Table 105: LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 106: Patient-derived Xenograft (PDX) Models Typical Customer List
Table 107: Patient-derived Xenograft (PDX) Models Distributors List
LIST OF FIGURES
Figure 1: Patient-derived Xenograft (PDX) Models Product Pictures
Figure 2: Mouse Model Picture Scope
Figure 3: Rat Model Picture Scope
Figure 4: Preclinical Drug development Picture Scope
Figure 5: Biomarker Analysis Picture Scope
Figure 6: Global Patient-derived Xenograft (PDX) Models Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 7: Global Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 8: Global Patient-derived Xenograft (PDX) Models Market Size by Region (2020-2032) & (US$ Million)
Figure 9: Global Patient-derived Xenograft (PDX) Models Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 10: North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 11: North America Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 12: North America Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 13: North America Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 14: US Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 15: Canada Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 16: Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 17: Europe Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 18: Europe Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 19: Europe Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 20: Germany Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 21: France Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 22: United Kingdom Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 23: Italy Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 24: Spain Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 25: Benelux Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 26: China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 27: China Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 28: China Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 29: China Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 30: APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 31: APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 32: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 33: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 34: Japan Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 35: South Korea Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 36: India Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 37: Australia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 38: Southeast Asia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 39: Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 40: Latin America Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 41: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 42: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 43: Mexico Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 44: Brazil Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 45: Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 46: Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 47: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 48: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 49: Saudi Arabia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 50: South Africa Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 51: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Key Suppliers in 2024
Figure 52: Global Patient-derived Xenograft (PDX) Models Industry Competition Landscape
Figure 53: Patient-derived Xenograft (PDX) Models Industry Chain Analysis
Figure 54: Bottom-Up and Top-Down Research Methods
Figure 55: Key Interview Objectives
Figure 56: Data Cross Validation
Figure 1: Patient-derived Xenograft (PDX) Models Product Pictures
Figure 2: Mouse Model Picture Scope
Figure 3: Rat Model Picture Scope
Figure 4: Preclinical Drug development Picture Scope
Figure 5: Biomarker Analysis Picture Scope
Figure 6: Global Patient-derived Xenograft (PDX) Models Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 7: Global Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 8: Global Patient-derived Xenograft (PDX) Models Market Size by Region (2020-2032) & (US$ Million)
Figure 9: Global Patient-derived Xenograft (PDX) Models Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 10: North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 11: North America Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 12: North America Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 13: North America Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 14: US Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 15: Canada Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 16: Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 17: Europe Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 18: Europe Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 19: Europe Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 20: Germany Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 21: France Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 22: United Kingdom Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 23: Italy Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 24: Spain Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 25: Benelux Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 26: China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 27: China Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 28: China Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 29: China Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 30: APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 31: APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 32: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 33: APAC (excl. China) Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 34: Japan Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 35: South Korea Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 36: India Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 37: Australia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 38: Southeast Asia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 39: Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 40: Latin America Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 41: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 42: Latin America Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 43: Mexico Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 44: Brazil Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 45: Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 46: Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 47: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2032)
Figure 48: Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2032)
Figure 49: Saudi Arabia Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 50: South Africa Patient-derived Xenograft (PDX) Models Revenue (2020-2032) & (US$ Million)
Figure 51: Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Key Suppliers in 2024
Figure 52: Global Patient-derived Xenograft (PDX) Models Industry Competition Landscape
Figure 53: Patient-derived Xenograft (PDX) Models Industry Chain Analysis
Figure 54: Bottom-Up and Top-Down Research Methods
Figure 55: Key Interview Objectives
Figure 56: Data Cross Validation
